Presbyopia Drops: A Foundation for Future Care - Scorecard - MDSpire

Presbyopia Drops: A Foundation for Future Care

Presbyopia drops are more than just a new tool—they’re a strategic entry point into the lifelong care pathway for patients with presbyopia.

  • By

  • Mitchell A. Jackson, MD

  • Melissa Bollinger, OD, FAAO

  • November 1, 2025

  • 7 min

Share

Clinical Scorecard: Presbyopia Drops: A Foundation for Future Care

At a Glance

CategoryDetail
Condition
Key MechanismsPharmacologic treatments like Qlosi and Vuity that provide temporary relief from near-vision loss.
Target Population
Care Setting

Key Highlights

  • Presbyopia drops serve as a strategic entry point into long-term eye care.
  • Customizable dosing regimens empower patients and enhance engagement.
  • Early positive experiences with drops influence future care decisions.
  • Clear communication and expectation management are critical for success.
  • Patients who start with drops are more likely to opt for premium IOLs when cataracts develop.
  • Patient education on the progressive nature of presbyopia is essential.

Guideline-Based Recommendations

Diagnosis

    Management

    • Offer presbyopia drops as a non-surgical alternative to glasses.
    • Schedule follow-up visits at 1 month and 3 months to assess patient satisfaction and adaptation.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Drops like Qlosi and Vuity can be used once or twice daily, providing flexibility based on lifestyle. Consideration for post-LASIK patients is also important.

        Clinical Best Practices

        • Educate patients on the nature of presbyopia and the role of drops.
        • Set realistic expectations regarding the adaptation period and effectiveness.
        • Foster a partnership approach to care, emphasizing ongoing engagement.
        • Monitor for side effects or adverse reactions to the drops.

        References

          Original Source(s)

          Presbyopia Drops: A Foundation for Future Care

          • by Mitchell A. Jackson, MD, Melissa Bollinger, OD, FAAO

          • November 1, 2025

          Related Content

          Profitable Presbyopia

          Presbyopia is no longer a condition we simply accommodate; it has become a platform for a longitudinal relationship that can span decades.

          Training Staff for the Presbyopia Journey

          Presbyopia isn’t new—but the way we treat it has changed dramatically. As we continue to embrace these advancements, let’s also commit to the one constant that always makes a difference: a well-trained, well-informed team.

          Women Prefer Contact Lens Under-Correction

          Clinic-based study suggests sex differences in preferred contact lens under-correction during presbyopia management